559 related articles for article (PubMed ID: 35331673)
1. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
5. Turning foes to friends: targeting cancer-associated fibroblasts.
Chen X; Song E
Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
[TBL] [Abstract][Full Text] [Related]
6. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
Pereira BA; Vennin C; Papanicolaou M; Chambers CR; Herrmann D; Morton JP; Cox TR; Timpson P
Trends Cancer; 2019 Nov; 5(11):724-741. PubMed ID: 31735290
[TBL] [Abstract][Full Text] [Related]
7. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
9. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
Patel AK; Singh S
Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
[TBL] [Abstract][Full Text] [Related]
10. What is new in cancer-associated fibroblast biomarkers?
Zhao Z; Li T; Yuan Y; Zhu Y
Cell Commun Signal; 2023 May; 21(1):96. PubMed ID: 37143134
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts: from basic science to anticancer therapy.
Yang D; Liu J; Qian H; Zhuang Q
Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
Sperb N; Tsesmelis M; Wirth T
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
14. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
16. Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.
Santi A; Kugeratski FG; Zanivan S
Proteomics; 2018 Mar; 18(5-6):e1700167. PubMed ID: 29280568
[TBL] [Abstract][Full Text] [Related]
17. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
18. A framework for advancing our understanding of cancer-associated fibroblasts.
Sahai E; Astsaturov I; Cukierman E; DeNardo DG; Egeblad M; Evans RM; Fearon D; Greten FR; Hingorani SR; Hunter T; Hynes RO; Jain RK; Janowitz T; Jorgensen C; Kimmelman AC; Kolonin MG; Maki RG; Powers RS; Puré E; Ramirez DC; Scherz-Shouval R; Sherman MH; Stewart S; Tlsty TD; Tuveson DA; Watt FM; Weaver V; Weeraratna AT; Werb Z
Nat Rev Cancer; 2020 Mar; 20(3):174-186. PubMed ID: 31980749
[TBL] [Abstract][Full Text] [Related]
19. Diversity and Biology of Cancer-Associated Fibroblasts.
Biffi G; Tuveson DA
Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
